Upstream Bioprocessing Global Market Report 2024

Description

Upstream bioprocessing involves preparing and cultivating cells to produce biological products such as proteins and vaccines. It focuses on cell line development and cell culture to create a scalable system that maximizes yield and quality, ensuring reproducibility and efficiency for downstream purification and formulation.

The primary products of upstream bioprocessing include bioreactors, fermenters, cell culture media, filters, and bags and containers. Bioreactors are vessels or tanks where biological reactions and processes occur under controlled conditions. The workflow includes media preparation, cell culture, and cell separation, with usage options including single-use and multi-use systems. These processes can be performed in-house or outsourced by various end users such as contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), research and academic institutes, and biopharmaceutical companies.

The upstream bioprocessing market research report is one of a series of new reports from The Business Research Company that provides upstream bioprocessing market statistics, including upstream bioprocessing industry global market size, regional shares, competitors with a upstream bioprocessing market share, detailed upstream bioprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the upstream bioprocessing industry. This upstream bioprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The upstream bioprocessing market size has grown rapidly in recent years. It will grow from $10.63 billion in 2023 to $12.03 billion in 2024 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to the increased need for process optimization and contamination-free, safe, and efficient production of biomolecules, commercial success, and rising demand for biotherapeutics. Additionally, there was a rise in the implementation of process analytical technology, an increase in chronic disease prevalence, and heightened research into the production of biosimilars.

The upstream bioprocessing market size is expected to see rapid growth in the next few years. It will grow to $19.84 billion in 2028 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to the commercial use of single-use bioreactors, the outsourcing of biopharmaceutical manufacturing, the rapid growth of the pharmaceutical and biotechnology industries, the rising adoption of single-use upstream bioprocessing, and increasing partnerships, mergers, acquisitions, and collaborations. Major trends in the forecast period include increasing investments in R&D in the biopharmaceutical industry, technological advancements, advanced upstream bioprocessing technologies, the development of new technologies, and advanced filtration technologies.

The growth of the upstream bioprocessing market is expected to be propelled by the outsourcing of biopharmaceutical manufacturing. This outsourcing involves delegating certain production stages to external entities such as contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs). It is driven by factors such as cost efficiency, focus on core competencies, flexibility in production scaling, access to specialized expertise, and risk mitigation. Outsourcing biopharmaceutical manufacturing accelerates product development by leveraging external expertise, streamlining operations, and reducing costs. For instance, BDO USA predicts that by 2025, contract development and manufacturing organizations along with hybrid manufacturing companies will control 44% of the global mammalian capacity of around 7,500kL. Hence, the outsourcing of biopharmaceutical manufacturing is a key driver of the upstream bioprocessing market's growth.

Leading companies in the upstream bioprocessing market are concentrating on developing advanced bioreactors tailored to cell culture processes, enhancing performance, flexibility, and scalability. Bioreactors are crucial tools in upstream bioprocessing, enabling efficient and controlled biopharmaceutical production through cell culture and biomolecule manufacturing. For example, in April 2023, Cytiva introduced X-platform bioreactors designed to streamline single-use upstream bioprocessing procedures. These bioreactors feature a modular design consisting of a tank, cabinet assembly, and human-machine interface (HMI), allowing flexible arrangements without the need for custom hardware or single-use bags. User-friendly features include an optimized vessel with a full-opening door, baffles, and improved cable management. Additionally, the online Bioreactor Scaler tool aids in determining optimal parameters for successful scale-up.

In May 2022, Lonza entered into a license agreement with Adva Biotechnology, granting Adva access to key intellectual property for the global expansion of automated bioreactors. This agreement provides Adva Biotechnology with a non-exclusive license to specific patents in Lonza's portfolio related to smart automation and bioreactor control. Adva Biotechnology, based in Israel, is focused on developing innovative technologies for upstream bioprocessing in the cell therapy industry.

Major companies operating in the upstream bioprocessing market are Thermo Fisher Scientific Inc., Danaher Corp, Merck KGaA, GE HealthCare Technologies, Parker Hannifin Corp, Corning Inc., AGC Biologics, Avantor, AGC Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Sartorius AG, Entegris Inc., Getinge AB, Bio-Rad Laboratories Inc., Samsung Biologics Co. Ltd., Eppendorf AG, Repligen Corporation, Takara Bio Inc., KBI Biopharma Inc., Rentschler Biopharma SE, Just Biotherapeutics Inc., PBS Biotech Inc., Stobbe Group, Applikon Biotechnology

North America was the largest region in the upstream bioprocessing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the upstream bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the upstream bioprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The upstream bioprocessing market consists of revenues earned by entities by providing services such as cell line development, inoculum preparation, process development and optimization, scale-up production, quality control and monitoring and raw material supply and management. The market value includes the value of related goods sold by the service provider or included within the service offering. The upstream bioprocessing market also includes sales of recombinant proteins, monoclonal antibodies, vaccines, gene therapy vectors, cell therapy products, enzymes, peptides, bio therapeutics and biosimilars. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Upstream Bioprocessing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on upstream bioprocessing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for upstream bioprocessing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The upstream bioprocessing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product type: Bioreactors; Fermenters; Cell Culture Media; Filters; Bags And Containers
2) By Workflow: Media Preparation; Cell Culture; Cell Separation
3) By Usage type: Single-Use; Multi-Use
4) By Mode: In House; Outsourced
5) By End User: Contract Development and Manufacturing Organization (CDMOs) Or Contract Research Organization (CROs); Research And Academic Institutes; Biopharmaceutical Companies
Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corp; Merck KGaA; GE HealthCare Technologies; Parker Hannifin Corp
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18501

1. Executive Summary

2. Upstream Bioprocessing Market Characteristics

3. Upstream Bioprocessing Market Trends And Strategies

4. Upstream Bioprocessing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Upstream Bioprocessing Market Size and Growth

5.1. Global Upstream Bioprocessing Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Upstream Bioprocessing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Upstream Bioprocessing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Upstream Bioprocessing Market Segmentation

6.1. Global Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Bioreactors
Fermenters
Cell Culture Media
Filters
Bags And Containers
6.2. Global Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Media Preparation
Cell Culture
Cell Separation
6.3. Global Upstream Bioprocessing Market, Segmentation By Usage type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Single-Use
Multi-Use
6.4. Global Upstream Bioprocessing Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
In House
Outsourced
6.5. Global Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Contract Development and Manufacturing Organization (CDMOs) Or Contract Research Organization (CROs)
Research And Academic Institutes
Biopharmaceutical Companies

7. Upstream Bioprocessing Market Regional And Country Analysis

7.1. Global Upstream Bioprocessing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Upstream Bioprocessing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Upstream Bioprocessing Market

8.1. Asia-Pacific Upstream Bioprocessing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Upstream Bioprocessing Market

9.1. China Upstream Bioprocessing Market Overview
9.2. China Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Upstream Bioprocessing Market

10.1. India Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Upstream Bioprocessing Market

11.1. Japan Upstream Bioprocessing Market Overview
11.2. Japan Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Upstream Bioprocessing Market

12.1. Australia Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Upstream Bioprocessing Market

13.1. Indonesia Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Upstream Bioprocessing Market

14.1. South Korea Upstream Bioprocessing Market Overview
14.2. South Korea Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Upstream Bioprocessing Market

15.1. Western Europe Upstream Bioprocessing Market Overview
15.2. Western Europe Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Upstream Bioprocessing Market

16.1. UK Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Upstream Bioprocessing Market

17.1. Germany Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Upstream Bioprocessing Market

18.1. France Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Upstream Bioprocessing Market

19.1. Italy Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Upstream Bioprocessing Market

20.1. Spain Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Upstream Bioprocessing Market

21.1. Eastern Europe Upstream Bioprocessing Market Overview
21.2. Eastern Europe Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Upstream Bioprocessing Market

22.1. Russia Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Upstream Bioprocessing Market

23.1. North America Upstream Bioprocessing Market Overview
23.2. North America Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Upstream Bioprocessing Market

24.1. USA Upstream Bioprocessing Market Overview
24.2. USA Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Upstream Bioprocessing Market

25.1. Canada Upstream Bioprocessing Market Overview
25.2. Canada Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Upstream Bioprocessing Market

26.1. South America Upstream Bioprocessing Market Overview
26.2. South America Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Upstream Bioprocessing Market

27.1. Brazil Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Upstream Bioprocessing Market

28.1. Middle East Upstream Bioprocessing Market Overview
28.2. Middle East Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Upstream Bioprocessing Market

29.1. Africa Upstream Bioprocessing Market Overview
29.2. Africa Upstream Bioprocessing Market, Segmentation By Product type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Upstream Bioprocessing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Upstream Bioprocessing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Upstream Bioprocessing Market Competitive Landscape And Company Profiles

30.1. Upstream Bioprocessing Market Competitive Landscape
30.2. Upstream Bioprocessing Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Danaher Corp
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck KGaA
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. GE HealthCare Technologies
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Parker Hannifin Corp
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Upstream Bioprocessing Market Other Major And Innovative Companies

31.1. Corning Inc.
31.2. AGC Biologics
31.3. Avantor
31.4. AGC Inc.
31.5. Boehringer Ingelheim International GmbH
31.6. Catalent Inc.
31.7. Sartorius AG
31.8. Entegris Inc.
31.9. Getinge AB
31.10. Bio-Rad Laboratories Inc.
31.11. Samsung Biologics Co. Ltd.
31.12. Eppendorf AG
31.13. Repligen Corporation
31.14. Takara Bio Inc.
31.15. KBI Biopharma Inc.

32. Global Upstream Bioprocessing Market Competitive Benchmarking

33. Global Upstream Bioprocessing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Upstream Bioprocessing Market

35. Upstream Bioprocessing Market Future Outlook and Potential Analysis

35.1 Upstream Bioprocessing Market In 2028 - Countries Offering Most New Opportunities
35.2 Upstream Bioprocessing Market In 2028 - Segments Offering Most New Opportunities
35.3 Upstream Bioprocessing Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer